U.S. Assisted Reproductive Technology Success Rates for 2022

Success rates for Assisted Reproductive Technology cycles started in 2022, reported by fertility clinics across the U.S. through the National ART Surveillance System. Data distinguishes between cycles using a patient's own eggs and those using donor eggs or embryos, with rates calculated per intended retrieval, actual retrieval, and transfer.

Use Cases

• Analyze cumulative success rates per intended retrieval for patients using their own eggs versus donor eggs.
• Compare success rates for patients with no prior ART cycles to the overall patient population using their own eggs.
• Examine the average number of transfers per intended retrieval or intended retrievals per live-birth delivery across clinics.
• Investigate success rates by types of embryos and eggs used in transfers for donor cycles.

Strengths

• Data originates from a national surveillance system covering clinics across the United States.
• Provides separate success rate calculations for distinct patient groups and cycle types (own eggs vs. donor).
• Reports cumulative success rates that account for transfers occurring within one year of an egg retrieval.

Limitations

• Excludes ART cycles classified as research, limiting analysis of experimental procedures.
• Success rates for donor egg/embryo cycles are not cumulative and are not broken down by patient age group.
• Dataset scope is limited to the single reporting year of 2022.

Provenance

Source

U.S. Department of Health & Human Services via the National ART Surveillance System (NASS).

Collection Method

Collected from fertility clinics across the U.S. as part of mandatory reporting.

Time Range

2022

Freshness

Data reflects cycles started in 2022; metadata was last updated in February 2025.

Geography

United States